down arrow

Samrat Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE103E01016
  • NSEID:
  • BSEID: 530125
INR
336.00
16 (5.0%)
BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 3.33 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

326.10344.60

52 Week

302.05646.00
Valuation
Technical
Day's Volume

CASH

3.33 k (62.90%) Volume

Shareholding (Dec 2024)

FII

3.24%

Held by 1 FIIs

DII

-0.00%

Held by 0 DIIs

Promoter

49.09%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate 8.24% of over the last 5 years

 
2

Stock is technically in a Bearish range

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 103 Cr (Micro Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.31%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

13.71%

stock-summary
Price to Book

1.52

Revenue and Profits (1 Year):
Net Sales:
64 Cr
(Quarterly Results - Dec 2024)
Net Profit:
3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.31%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-39.13%
0%
-39.13%
1 Year
-11.08%
0.26%
-10.82%
2 Years
-29.05%
0.37%
-28.68%
3 Years
-31.94%
0.78%
-31.16%
4 Years
133.5%
1.30%
134.8%
5 Years
306.29%
3.96%
310.25%

Latest dividend: 1 per share ex-dividend date: Sep-19-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
15.66%
EBIT Growth (5y)
8.24%
EBIT to Interest (avg)
11.74
Debt to EBITDA (avg)
1.63
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
4.02
Tax Ratio
23.45%
Dividend Payout Ratio
1.86%
Pledged Shares
0
Institutional Holding
3.24%
ROCE (avg)
25.55%
ROE (avg)
20.38%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
33
Price to Book Value
1.52
EV to EBIT
9.04
EV to EBITDA
8.52
EV to Capital Employed
1.53
EV to Sales
0.33
PEG Ratio
NA
Dividend Yield
0.31%
ROCE (Latest)
4.93%
ROE (Latest)
13.71%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (3.24%)

Promoter with highest holding

Lalit Damodar Mehta (13.97%)

Highest Public shareholder

Sangeetha S (3.27%)

Individual Investors Holdings

41.95%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -9.28% vs -13.18% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 4.51% vs 28.50% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "63.66",
          "val2": "70.17",
          "chgp": "-9.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.17",
          "val2": "3.36",
          "chgp": "24.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.17",
          "chgp": "-41.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.78",
          "val2": "2.66",
          "chgp": "4.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.55%",
          "val2": "4.79%",
          "chgp": "1.76%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 10.04% vs -12.94% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 1,026.19% vs -97.25% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "151.00",
          "val2": "137.22",
          "chgp": "10.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.95",
          "val2": "1.00",
          "chgp": "495.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "0.35",
          "chgp": "2.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.73",
          "val2": "0.42",
          "chgp": "1,026.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.94%",
          "val2": "0.73%",
          "chgp": "3.21%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 7.93% vs -17.63% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 888.16% vs -95.63% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "214.66",
          "val2": "198.89",
          "chgp": "7.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.12",
          "val2": "1.11",
          "chgp": "811.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.46",
          "val2": "0.58",
          "chgp": "-20.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "7.51",
          "val2": "0.76",
          "chgp": "888.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.71%",
          "val2": "0.56%",
          "chgp": "4.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -9.36% vs 40.05% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -87.01% vs -3.20% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "281.58",
          "val2": "310.65",
          "chgp": "-9.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.47",
          "val2": "23.93",
          "chgp": "-89.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.69",
          "val2": "1.23",
          "chgp": "-43.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.16",
          "val2": "16.63",
          "chgp": "-87.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.88%",
          "val2": "7.70%",
          "chgp": "-6.82%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
63.66
70.17
-9.28%
Operating Profit (PBDIT) excl Other Income
4.17
3.36
24.11%
Interest
0.10
0.17
-41.18%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.78
2.66
4.51%
Operating Profit Margin (Excl OI)
6.55%
4.79%
1.76%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -9.28% vs -13.18% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 4.51% vs 28.50% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
151.00
137.22
10.04%
Operating Profit (PBDIT) excl Other Income
5.95
1.00
495.00%
Interest
0.36
0.35
2.86%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.73
0.42
1,026.19%
Operating Profit Margin (Excl OI)
3.94%
0.73%
3.21%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 10.04% vs -12.94% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 1,026.19% vs -97.25% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
214.66
198.89
7.93%
Operating Profit (PBDIT) excl Other Income
10.12
1.11
811.71%
Interest
0.46
0.58
-20.69%
Exceptional Items
0.00
0.00
Standalone Net Profit
7.51
0.76
888.16%
Operating Profit Margin (Excl OI)
4.71%
0.56%
4.15%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 7.93% vs -17.63% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 888.16% vs -95.63% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
281.58
310.65
-9.36%
Operating Profit (PBDIT) excl Other Income
2.47
23.93
-89.68%
Interest
0.69
1.23
-43.90%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.16
16.63
-87.01%
Operating Profit Margin (Excl OI)
0.88%
7.70%
-6.82%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -9.36% vs 40.05% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -87.01% vs -3.20% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Samrat Pharmachem Ltd stock-summary
stock-summary
Samrat Pharmachem Ltd
Micro Cap
Pharmaceuticals & Drugs
Samrat Pharmachem Limited was incorporated on June 16, 1992. The Company's principal activities are manufacturing and selling chemicals. The Company floated a new 100% subsidiary company during the year 2003-04 named as Samrat Remedies Limited to carry on activities of Manufacturing of Pharmaceutical Bulk Drugs & Chemicals.
Company Coordinates stock-summary
Company Details
Plot No A2/3445, GIDC Phase IV Ankleshwar Gujarat : 393002
stock-summary
Tel: 91-2646-220774
stock-summary
http://www.samratpharmachem.com
stock-summary
samrat@bom4.vsnl.net.in
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."